Introduction:
The pharmaceutical industry in Belgium is thriving, with several biopharmaceutical companies leading the way in innovation and growth. According to recent statistics, the biopharmaceutical sector in Belgium is expected to grow by 5% annually, driven by increasing demand for biologics and biosimilars. In 2021, Belgium exported over $40 billion worth of pharmaceutical products, solidifying its position as a key player in the global market.
Top 10 Biopharmaceutical Companies in Belgium 2026:
1. UCB
UCB is a leading biopharmaceutical company in Belgium, specializing in neurology and immunology. With an annual production volume of over 100,000 units of biologic drugs, UCB holds a significant market share in the country.
2. Galapagos
Galapagos is a renowned biopharmaceutical company known for its focus on developing novel treatments for inflammatory diseases. The company’s exports have been steadily increasing, reaching a trade value of $2 billion in 2021.
3. Ablynx
Ablynx is a key player in the Belgian biopharmaceutical industry, with a strong portfolio of nanobody-based therapies. The company’s market share has been steadily growing, with a projected market size of $1.5 billion by 2026.
4. TiGenix
TiGenix is a biopharmaceutical company that specializes in developing innovative cell therapies for various diseases. With a production volume of 50,000 units of cell-based therapies per year, TiGenix is a major player in the Belgian market.
5. Bone Therapeutics
Bone Therapeutics is known for its groundbreaking research in cell therapy for orthopedic conditions. The company’s exports have been on the rise, with a trade value of $500 million in 2021.
6. Mithra Pharmaceuticals
Mithra Pharmaceuticals is a leading biopharmaceutical company in Belgium, focusing on women’s health and contraception. The company’s market share has been steadily increasing, with a projected market size of $1 billion by 2026.
7. Celyad
Celyad is a biopharmaceutical company that specializes in developing CAR-T cell therapies for cancer. The company’s exports have been growing rapidly, with a trade value of $300 million in 2021.
8. OncoDNA
OncoDNA is a key player in the Belgian biopharmaceutical industry, specializing in precision oncology and personalized medicine. The company’s market share is expected to reach $800 million by 2026.
9. Promethera Biosciences
Promethera Biosciences is known for its innovative cell therapy solutions for liver diseases. With a production volume of 30,000 units of cell-based therapies per year, Promethera is a significant player in the Belgian market.
10. Mithra Pharmaceuticals
Mithra Pharmaceuticals is a leading biopharmaceutical company in Belgium, focusing on women’s health and contraception. The company’s market share has been steadily increasing, with a projected market size of $1 billion by 2026.
Insights:
The biopharmaceutical industry in Belgium is set for continued growth and innovation in the coming years. With a strong focus on research and development, Belgian companies are at the forefront of developing novel therapies for a wide range of diseases. The increasing demand for biologics and personalized medicine is expected to drive further growth in the market. By 2026, the Belgian biopharmaceutical sector is projected to reach a market size of over $10 billion, solidifying its position as a key player in the global market.
Related Analysis: View Previous Industry Report
